We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1066:HKEXRHB Bank Berhad Analysis

Data as of 2026-03-16 - not real-time

MYR 8.22

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

RHB Bank Berhad shows a clear bullish bias on the chart, with the short‑term moving average comfortably above both the mid‑term and long‑term averages, while price is holding just above a well‑defined support zone and below a nearby resistance level. Volume has been picking up, reinforcing the upward bias, although the MACD histogram remains in negative territory, hinting at lingering short‑term weakness, and the RSI sits in the mid‑40s, suggesting room for upside without immediate overbought pressure.
Fundamentally, the stock trades at a price‑to‑earnings multiple well below the sector average, and its price‑to‑book ratio hovers just above one, indicating a modest discount to book value. A dividend yield north of six percent, coupled with a payout ratio around the mid‑fifties, makes the yield attractive, but negative operating cash flow raises questions about long‑term sustainability. Analysts collectively rate the stock as a buy, with consensus price targets implying roughly a nine percent upside, and market sentiment is in a “greed” mode according to the fear‑and‑greed index.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • price near support with bullish SMA alignment
  • increasing volume supporting the trend
  • MACD still negative, limiting upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation discount relative to peers
  • high dividend yield enhancing total return
  • analyst consensus price target indicating upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • stable earnings profile and solid book value
  • reasonable payout ratio despite cash‑flow concerns
  • low beta suggesting limited market volatility exposure

Key Metrics & Analysis

Financial Health

Revenue Growth8.60%
Profit Margin39.29%
P/E Ratio10.7
ROE10.10%
ROA0.95%
P/B Ratio1.1
Op. Cash FlowMYR-14806689792
Industry P/E16.4

Technical Analysis

TrendBullish
RSI46.0
SupportMYR 8.08
ResistanceMYR 8.65
MA 20MYR 8.36
MA 50MYR 8.19
MA 200MYR 7.06
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target PriceMYR 8.99
Upside/Downside9.34%
GradeUndervalued
TypeBlend
Dividend Yield6.03%

Risk Assessment

Beta0.27
Volatility26.44%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.